Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID‐19: The GIMEMA EMATO‐0321 study

COVID‐19 continues to be a relevant issue among patients with haematological malignancies (HM). Vaccines are frequently not effective in subjects on active treatment. In this multicentre retrospective study of Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA), we collected data from 91...

Descripción completa

Detalles Bibliográficos
Autores principales: Marasco, Vincenzo, Piciocchi, Alfonso, Candoni, Anna, Pagano, Livio, Guidetti, Anna, Musto, Pellegrino, Bruna, Riccardo, Bocchia, Monica, Visentin, Andrea, Turrini, Mauro, Tucci, Alessandra, Pilerci, Sofia, Fianchi, Luana, Salvini, Marco, Galimberti, Sara, Coviello, Elisa, Selleri, Carmine, Luppi, Mario, Crea, Enrico, Fazi, Paola, Passamonti, Francesco, Corradini, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Covid‐19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796521/
https://www.ncbi.nlm.nih.gov/pubmed/35906881
http://dx.doi.org/10.1111/bjh.18385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796521/
https://www.ncbi.nlm.nih.gov/pubmed/35906881
http://dx.doi.org/10.1111/bjh.18385

Ejemplares similares